Highlights d AGO1 enrichment on chromatin and transcriptional enhancers is mediated by eRNAs d AGO1 depletion alters global transcriptional output including eRNA transcripts d Enhancer-associated AGO1 contributes to the maintenance of 3D chromatin organization
INTRODUCTION
Argonaute (AGO) proteins are key members of the RNA interference (RNAi) pathway and are well documented for their role in small RNA-mediated post-transcriptional gene silencing in the cytoplasm (Meister, 2013; Joshua-Tor and Hannon, 2011) . In fission yeast, AGO proteins and small RNAs are essential for heterochromatin formation (Volpe et al., 2002) and, similarly, in plants, for RNA-dependent DNA methylation (Zilberman et al., 2003) . However, the function of RNAi components in animal cell chromatin organization-mediated transcriptional regulation remains unclear. We previously reported that in Drosophila, RNAi components (dAgo2 and Dicer) are preferentially associated with active chromatin and affect transcription by regulating RNA pol II pausing and stress response (Cernilogar et al., 2011) . Another report indicated that in Drosophila, dAgo2 associates with insulator proteins CTCF and CP190 at active promoters and controls looping interactions between insulators, promoters, and enhancers (Moshkovich et al., 2011) . In human cells, AGO1 binds to RNA pol II (Huang et al., 2013) to associate with active promoters, enhancers (Alló et al., 2014) , HP1a, and CTCF (Agirre et al., 2015) and affects splicing (Alló et al., 2014; Ameyar-Zazoua et al., 2012; Agirre et al., 2015) . However, the role of chromatin-associated AGO1 in regulating gene expression remains to be elucidated. A study showed AGO1 binding with RNA polymerase II and active promoters (Huang et al., 2013) , while another report indicated that AGO1 association with active enhancers did not explain the observed widespread changes in gene expression in AGO1 depleted cells (Alló et al., 2014) . In particular, it seemed important to understand whether enhancer-associated AGO1 can directly or indirectly impact transcription.
Enhancers are cis-regulatory elements in the mammalian genome that orchestrate gene expression programs by direct looping or indirect contacts with target gene promoters (Bulger and Groudine, 2011; Ong and Corces, 2011) . Enhancer loci generally undergo bidirectional transcription by RNA pol II to produce enhancer RNAs (eRNAs) (Natoli and Andrau, 2012) . The association of AGO1 with active enhancers was postulated (legend continued on next page) to be mediated by enhancer RNAs (Alló et al., 2014) . Both enhancer elements and eRNAs are implicated in higher-order chromatin interactions that play an essential role in gene regulation (Hah et al., 2013) . Recently, genome-wide chromosome conformation capture analysis (Hi-C) has revealed that chromosomes are organized into active (open, A-type) and inactive (closed, B-type) compartments , which are further composed of clusters of interactions called topologically associated domains (TADs), separated by boundary regions (Dixon et al., 2012; Nora et al., 2012) . The 3D chromatin structure is believed to regulate gene expression by establishing loops between enhancers and promoters and/or by bridging regulatory elements and genes into spatial chromatin hubs, compartments, and domains (Bouwman and de Laat, 2015) . Several chromatin regulators, including polycomb proteins, cohesin, CTCF, and mediator complex have been reported to influence 3D genome organization (Sofueva et al., 2013; Zuin et al., 2014; Kagey et al., 2010; Seitan et al., 2013; Delest et al., 2012) . However, a potential contribution of enhancer-associated AGO1 in three-dimensional chromatin (3D) organization has not yet been tested.
Here, by using a combination of genome-wide approaches, we provide evidence for an unexpected role of AGO1 in chromatin topological organization. We demonstrate that AGO1 binds at active chromatin regions mainly on proximal and distal enhancers. AGO1 depletion changes the 3D genome architecture leading to differential interactions, derangement of TADs configuration, and chromatin compartments that correlate with changes in gene expression. Collectively, these findings unveil an unprecedented link between enhancer-associated AGO1, the stability of higher-order chromatin architecture, and maintenance of proper gene expression program in human cells.
RESULTS

AGO1 Associates with Chromatin and Its Depletion Results in Deregulation of Coding and Non-coding Transcripts at Genome-wide Level
To understand the function of endogenous AGO proteins inside the nucleus, we first examined their nuclear and chromatin association. After cellular fractionation of HepG2 cells, the western blot analysis revealed that AGO1 was more enriched compared to AGO2-4 in the chromatin-bound fraction (Figure 1A) . AGO1 nuclear distribution was further confirmed by immunofluorescence using AGO1-specific antibody ( Figure 1B) . Therefore, we focused our subsequent analysis only on AGO1 and its potential nuclear function. To evaluate the impact of AGO1 depletion on global transcriptional changes of all expressed TSS, we decided to use CAGE-seq analysis (Takahashi et al., 2012) . We knocked down AGO1 with a pool of four siRNAs (siAGO1) and performed a control knockdown (KD) using a non-specific scrambled siRNA (siCtrl) in HepG2 cells. The efficiency of knockdown for each individual single siRNA was also tested. We confirmed the downregulation of AGO1 by western blot and immunofluorescence analysis (Figures S1A-S1C). AGO1-depleted cells showing a similar pattern of cell viability ( Figure S1D ) and cell-cycle profiles compared to control KD cells ( Figure S1E ) were processed for further analysis. We then applied CAGE-seq on total and chromatin extracted RNA from control (siCtrl) and AGO1 depleted (siAGO1) cells. All three replicates in each condition showed a similar clustering pattern between themselves as represented in PCA plot ( Figure S1F ). We identified more than 1,000 genes in both total and chromatin-bound RNA CAGE-seq data that were differentially expressed (DE) ( Figures 1C-1E and for detail see Table S1 ). By comparing CAGE-seq data from total RNA and chromatin-bound RNA, we observed 171 common differentially expressed genes in the two fractions ( Figure 1F ). Considering only the highly perturbed genes (FDR % 0.05), we found that 512 genes were upregulated, whereas 226 genes showed downregulation in total RNA-CAGE. Similarly, 213 upregulated genes and 170 downregulated genes were found in CAGE data from chromatin-bound RNAs ( Figure 1G ). These observations indicate that loss of AGO1 has both a positive and negative impact on gene expression ( Figure 1G ). We further extended our analysis to find a possible correlation between perturbed transcripts and deregulated miRNAs. To this, we compared small RNA-seq data with CAGE-seq in control and AGO1depleted cells. The majority (95%) of perturbed mRNAs were not direct targets of differentially expressed miRNAs ( Figures  S2A-S2B ). Moreover, we did not observe any good correlation between the effect of down and upregulated miRNAs and the expression of predicted targets ( Figures S2C-S2E ).
To discriminate between directly and indirectly regulated genes, we integrated CAGE-seq with AGO1 binding sites on chromatin (ChIP-seq). Among all the differentially expressed genes, we observed AGO1 binding at about 29% (274) genes, but only 16% (43) of these genes overlapped with AGO1 peaks at their promoters. In contrast, for the majority of perturbed genes (71%), we did not detect AGO1 at their promoters or within the coding region ( Figure 1H ). However, we observed a clear enrichment of AGO1 binding at the predicted enhancers located within <50 kb of all the differentially expressed genes ( Figure 1I ). These results suggest that AGO1 may alter predominant gene expression via binding at potential distal regulatory regions, though mechanistic aspects remained to be clarified.
The putative active enhancers are marked by bidirectional transcription of nuclear enhancer RNAs (eRNAs) that can be detected by CAGE . By using chromatin CAGE-seq data, we identified 5,538 and 3,574 putative active eRNA loci in siCtrl and siAGO1 cells, respectively. Similarly, from total RNA CAGE, we identified 3,574 and 4,687 CAGE-predicted eRNAs in siCtrl and siAGO1 cells, respectively. To obtain information about eRNA dynamics upon AGO1 depletion, we focused on 573 ( from chromatin) and 476 (from total) CAGEidentified eRNAs that were common between siCtrl and siAGO1 (H) Integration of ChIP-seq and AGO1-knockdown CAGE-seq data classify AGO1-responsive genes into direct and indirect targets. 29% of all differentially expressed (DE) genes (from total and chromatin CAGE-seq combined) contain AGO1 binding at their promoter or intragenically, represent direct targets. 71% do not overlap with AGO1 peaks (means indirect targets). (I) Density plot of AGO1 ChIP-seq peaks closer than 50 kb to genes (either differentially expressed or considering all genes) centered at enhancer regions predicted by ChromHMM. Tables S2 and S3 ). We observed apparent differences in the expression level (TPM values, Tags Per Million) of eRNAs between siCtrl and siAGO1 cells (Figures S1G-S1H).
cells (for detail see
AGO1 Is Strongly Enriched at Transcriptionally Active Enhancers via RNA
To identify AGO1 genomic distribution in human HepG2 cells, we performed ChIP-seq (for antibody specificity, see Figures S1A-S1C). AGO1 ChIP-seq data analysis revealed approximately 80% mapping rate, and we identified 17,771 reproducible AGO1-specific peaks (for detailed AGO1 ChIP peak annotation, see Table S4 ). Examining the annotation of these peaks, we found AGO1 peak distribution in genic (introns and promoters) and inter-genic regions (Figure 2A ; see Figure S3 for comparison of AGO1 and HA-AGO1 ChIP-seq). We validated the binding of AGO1 on selected target regions using ChIP-qPCR experiment in control and AGO1-depleted cells (Figures S4A and S4B and for detail of primer sequence used, see Table S5 ). The distribution of AGO1 peaks in intronic and intergenic regions (Figure 2A) may represent potential enhancers. Thus, we overlaid AGO1 ChIP-seq peaks with the chromatin states of HepG2 cells predicted by the combination of ChromHMM and Segway. Most represented classes were promoters and predicted strong enhancer regions ( Figure 2B ). We further categorized AGO1 peaks into three classes, i.e., promoter, proximal, and distal regions based on distance from TSS (promoter = 1kb up or downstream, proximal = within 5kb, and distal regions = 5kb up to 50kb). The majority of AGO1 peaks are associated with distal regions ( Figure 2C ). To check that these sites are indeed enhancers, we used publicly available ENCODE HepG2 histone ChIP-seq datasets associated with enhancer and promoter regions (H3K4me1, H3K4me3, H3K27ac, and H3K9ac). (C) Bar plot shows percent enrichment of AGO1 ChIP-seq peaks at distal, promoter, and proximal regions. AGO1 peaks are highly enriched in distal regions (i.e., >5 kb from nearest annotated TSS). AGO1 peaks also associate with promoter region (i.e., <1 kb from nearest annotated TSS). (D) Density plot of ChIP-seq signals (median) of AGO1 and histone marks from ENCODE datasets including H3K4me1, H3K4me3, H3K9ac, and H3K27ac centered at AGO1 peak located in distal, proximal, and promoter regions. AGO1-bound distal regions are enriched with active enhancer marks such as H3K4me1, H3K27ac, and H3K4me3 representing transcriptionally active enhancers.
(E) Density of CAGE-seq signals represents transcriptional activity at AGO1-binding sites (promoter, proximal, and distal). The low level of transcriptional activity at AGO1-enriched distal regulatory elements indicates enhancer RNAs (eRNAs).
AGO1-enriched promoter sites showed clear overlap with active TSS marks (H3K27ac, H3K9ac, and H3K4me3) but not with H3K4me1 ( Figure 2D ). The AGO1-bound distal regions overlapped active enhancer marks such as H3K4me1, H3K27ac, and H3K4me3 ( Figure 2D ). Next, by overlapping all expressed TSS tags from CAGE-seq with AGO1 peaks, we observed a clear correlation with RNAs produced at those sites ( Figure 2E ).
To clarify the involvement of RNAs in AGO1 chromatin association, we performed cross-linked AGO1 RIP-seq from chromatin-bound AGO1-associated RNAs in the nucleus. We then intersected all identified AGO1-associated RNA peaks (including coding, non-coding, and un-annotated peaks) with AGO1bound (ChIP-seq) and -unbound chromosomal regions across the genome. We found enrichment of RNA peaks on AGO1bound active sites when compared to AGO1-absent sites in the genome ( Figure 3A ). We next examined whether RNA binding of AGO1 contributes to its chromatin association. After chromatin fractionation in the presence and absence of RNase treatment, the level of AGO1 protein was detected by western blotting. We observed that RNase treatment highly reduced AGO1 protein level in the chromatin fraction ( Figures 3B and 3C ). Thus, RNA binding stabilizes AGO1 chromatin association.
The AGO1-enriched proximal and distal regions showed a low level of transcriptional activity that may represent putative enhancer RNAs (eRNAs) ( Figure 2E ). To investigate the association between chromatin-bound AGO1 and eRNAs, we first examined AGO1 binding at putative eRNAs loci identified by CAGE. We found a clear enrichment of AGO1 ChIP signals around chromatin CAGE-defined eRNAs midpoint (Figures 3D and 3E) . We then intersected the chromatin CAGE-defined eRNA loci with our AGO1 binding sites (ChIP peaks). Of 5,538 CAGE-identified eRNA loci, 573 putative eRNAs exactly overlapped with AGO1-bound enhancer regions across the genome (Table S6 ). Next, we overlaid this list of 573 putative eRNAs with active enhancer marks H3K4me1 and H3K27ac (ENCODE HepG2 histone ChIP) and with GRO-seq data recently published in HepG2 cells (Bouvy-Liivrand et al., 2017) . Among these, 94 CAGE-identified eRNAs overlapped with H3K4me1, H3K27ac, and GRO-seq peaks (Table S7 ). To validate the requirement of transcriptionally active eRNAs and enhancer-like long-non-coding RNAs (lncRNAs) for AGO1 enhancer association, we investigated AGO1 binding on some randomly selected enhancer loci (as defined by chromatin-CAGE, Table S7 ) upon inhibition of RNA polymerase II by actinomycin D treatment. Upon transcription inhibition, both eRNAs (sense and antisense) and AGO1 ChIP signals are significantly reduced in 9 selected CAGEdefined enhancer regions ( Figures 3F and 3G ), which certify AGO1 enrichment at transcriptionally active enhancers is mediated by eRNAs.
AGO1 Depletion Alters Chromatin Interactions Specifically in AGO1-Bound Regions
Since AGO1 binding at distal regulatory elements indirectly impacts global gene expression, we hypothesized a role of nuclear AGO1 in higher-order chromatin organization. To this scope, we performed an unbiased genome-wide chromatin conformation analysis using Hi-C in siCtrl and siAGO1 HepG2 cells ( Figure S5) . At the global level, the chromosomal interaction frequency heatmaps for each individual chromosome dis-played similar patterns in both siAGO1 and siCtrl cells ( Figures  4A and 4B ). To gain deeper insight into differential interaction frequencies between siCtrl and siAGO1 cells, we compared normalized HiC data (siAGO1 versus siCtrl) with the R package diffHiC (Lun and Smyth, 2015) . The diffHiC analysis revealed differences in genome-wide chromatin interactions between siAGO1 and siCtrl cells ( Figures 4C and 4D) . Upon AGO1 depletion, we observed extensive changes in both long-range and short-range interaction frequency across the genome (Figures 3C and 3D ). Next, we asked whether changes in chromosomal interactions were correlated with AGO1 binding sites. We found that 93% of AGO1 binding sites (16,566 AGO1 peaks) overlapped with differential interacting regions at the genomewide level (Figures 4E, S5F, and S5G ). We then calculated the difference in the number of differential interactions between AGO1 enriched and without AGO1 binding 20-kb bins. We observed significantly (t test < 0.05) higher number of differential interactions between bin-pairs containing AGO1 binding sites than without AGO1 binding ( Figure 4F ). In particular, upon AGO1 depletion, we observed a decrease in chromosomal interaction frequency among AGO1 binding sites, with a simultaneous gain in chromatin interactions at other genomic loci (Figure 4G) . Overall, these data suggest that AGO1 binding at genomic regulatory sites has influence on their higher-order chromatin interactions.
AGO1 Depletion Perturbs Compartments and TADs
Organization at AGO1-Associated Genomic Regions Models derived from omics data analysis (HiC) indicate that the genome is partitioned into active (open, A-type) and inactive (closed, B-type) compartments Rao et al., 2014) . Thus, we first investigated the effects of AGO1 depletion on the A/B chromatin compartmentalization. We defined chromatin compartments (A and B) using the first principal component (PC1) by eigenvector analysis (Zhang et al., 2012) . To further demarcate A/B chromatin compartments, we also intersected expressed genes (identified by CAGE-seq) with eigenvector values. We then compared the genome-wide compartments between siCtrl and siAGO1 cells at 100-kb resolution. The siAGO1 cells displayed a highly mixed A and B compartmentalization pattern ( Figure 5A ). We found that 14% of the siAGO1 genome showed compartments switching, which predominantly occurred in the AGO1-bound open A-type compartment (Figures 5B and 5C) .
To examine the effect on TAD organization, we first identified 3,143 and 3,593 TADs in siCtrl and siAGO1 cells, respectively, using TADbit tool (Serra et al., 2016) (Figure 6A ). Next, we assessed the distribution of TADs within A/B compartments. TADs were placed in either A or B compartment, then by comparing siAGO1 and siCtrl genome, we found that around 12% of TADs switched from A-type to B-type compartment at a genome-wide level ( Figure 6B ). We consistently found that in siAGO1 TADs size was smaller compared to siCtrl cells (t test, FDR < 0.05) ( Figure 6C ). Then, by visualizing the topological domains in AGO1-depleted cells, we frequently observed that larger domains found in siCtrl cells were divided into smaller sub-domains ( Figure 6D ). Additionally, we found that 25% of AGO1 binding sites (detected by ChIP-seq) overlapped with TAD boundaries identified at 100-kb resolution ( Figure 6E ). Table S5 .
Finally, although there are differences in the numbers and size of TADs in siAGO1 cells, TAD boundaries between siCtrl and siAGO1 cells were largely maintained ( Figure 6F ). These results suggest that AGO1 binding at transcriptionally active enhancers contribute to the maintenance of global chromatin organization at specific genomic regions.
AGO1-Dependent Changes in 3D Genome Architecture Are Associated with Differential Gene Expression
To determine whether AGO1-dependent changes in chromatin topological structure correlated with differential gene expression, we applied an integrative approach by combining tran-scriptome (CAGE-seq) with Hi-C and AGO1 ChIP-seq analyses. We first examined the effect of changes in compartmentalization on gene expression. We found that in siAGO1 cells, 20% of differentially expressed genes were associated with disorganized chromatin compartments ( Figures 7A-7C ). Furthermore, the majority of deregulated genes that reside within topological domains, or near domain borders, overlapped with extensive changes in chromosomal interactions following AGO1 knockdown ( Figure 7D ). Next, all deregulated genes (FDR % 0.05 and log 2 FC >1.2) located within differential interacting bins (DI bin) were further classified into two categories based on overlapping with either (1) compartment switching or (2) in TADs configuration ( Figure 7E ). Furthermore, deregulated genes only from chromatin CAGE data were integrated with Hi-C changes into different categories (Figures S6A and S6B) .
The changes in expression of randomly selected perturbed genes (AGO1 KD CAGE-seq) located within differentially interacting bins (AGO1 KD Hi-C) were further confirmed by RT-qPCR ( Figures S6C-S6F) . Altogether, around 80% of deregulated genes are correlated with differential interactions (both cis-and trans interactions) ( Figures 7F and 7G) , and a subset of these genes is affected by compartment transitions (Fig-ure 7A ) upon AGO1 depletion. These results suggest a role for enhancer-associated AGO1 in maintaining proper transcriptional program by contributing to chromatin topological organization.
DISCUSSION
It has now become evident that AGO1 is present inside the nuclei of mammalian cells and affects multiple nuclear processes, including transcription and splicing. In this work, we report a siCtrl-chromosome1 . Dotted lines delimit compartment borders. Expressed genes represent all genes identified by CAGE-seq both non-significant (genes with a basemean expression higher than 20 but not upregulated upon AGO1 knockdown) and significant genes (with a basemean expression higher than 20 and being upregulated for siAGO1 and downregulated for siCtrl cells).
link between enhancer-associated AGO1, higher-order chromatin organization, and gene expression regulation.
In humans, there are four AGO proteins (AGO1-4) (Sasaki et al., 2003) , in which only AGO2 and AGO3 possess slicer activity (Meister et al., 2004; Park et al., 2017) . Unlike AGO4, which is mainly germline associated (Modzelewski et al., 2012) , the noncatalytic AGO1 is broadly expressed in many tissues. Currently, it is unclear whether different AGO proteins (AGO1-4) might play a similar function in the nucleus. AGO1 depletion appears to increase AGO2 nuclear levels and also affect the nuclear redistribution of other RNAi factors (Matsui et al., 2015) . Our data show that compared to AGO2-4, AGO1 proteins mostly enrich in the chromatin fractions. Also, AGO1 and AGO2 have been shown to display differential nuclear localization, with AGO1 being present in the nuclear interior and AGO2 only at the periphery (Huang et al., 2013) . Unlike AGO1, AGO2 ChIPseq analysis does not detect widespread genomic distribution (Huang et al., 2013) . Notably, a recent study (van Eijl et al., 2017) reported about the cross-reactivity of another AGO2 antibody (11A9) with SMARCC1. The same antibody was previously used for ChIP (Ameyar-Zazoua et al., 2012) and protein immunoprecipitation (SWI/SNF) (Carissimi et al., 2015) . Though AGO2 appears to be slightly present in chromatin fraction (as detected by western blot), its nuclear function and the genomewide association remains unclear. Any direct or indirect mechanistic evidence that AGO2/3 would compensate for AGO1 nuclear function remains to be reported.
However, the absence of a functional slicing domain in AGO1 protein indicates its nuclear function to be independent of RNAprocessing, but instead, involves RNA binding, mostly ncRNA. (legend continued on next page)
The mechanistic explanation of the impact of AGO1 depletion on higher-order chromatin organization remains to be understood. The role of RNA as an essential component of nuclear structure has been recognized for a long time (Nickerson et al., 1989; Holmes et al., 1972) . Emerging evidence in the field of 3D genome architecture highlights the involvement of non-coding RNAs (ncRNA) in this process (Melé and Rinn, 2016; Yang et al., 2013; Cerase et al., 2015; Hacisuleyman et al., 2014) . Our RIP-seq analysis in HepG2 cells identified a plethora of ncRNA moieties that are associated with chromatin-bound AGO1 and overlapped with its binding sites across the genome. Therefore, we anticipate that the RNA targets coordinating in AGO1 nuclear function are more than one. Genome-wide binding of AGO1 at transcriptionally active enhancers may suggest its role in shaping chromatin structure and gene expression by coordinating with ncRNAs, particularly eRNAs. Enhancer regions are often transcribed in a bidirectional manner by RNA polymerase II and produce eRNAs (Kim et al., 2010) . The eRNAs have been shown to be involved in gene regulation by different mechanism such as controlling enhancer looping interactions (Hsieh et al., 2014; Hah et al., 2011) , chromatin accessibility (Mousavi et al., 2013) , and their direct interaction with CBP control enhancer activity and transcription (Bose et al., 2017) . AGO1 has been shown to interact with RNA pol II across active enhancers (Huang et al., 2013; Alló et al., 2014) and may be required for eRNAs transcription. Indeed, upon AGO1 depletion, we observed obvious changes in the expression level of CAGE-defined eRNAs. These CAGE-identified eRNAs are produced from AGO1-bound enhancer regions. Moreover, the enrichment of AGO1 at active cis-regulatory elements depends on eRNAs expression, suggesting eRNAs function as a potential bridge between AGO1, chromatin association, and gene expression. AGO1, in association with eRNAs might control enhancer activity that could contribute to higher-order chromatin organization. AGO1, being a strong RNA binding protein, may play a role in establishing protein-RNA networks inside the nucleus that are essential for the stability of cell type-specific gene expression programs. Future work will, therefore, be required to investigate the mechanistic functional link between enhancer-associated AGO1 and eRNAs in the control of 3D genome organization and gene expression homeostasis.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (D) A representative plot of chromosome 12 showing (1) differential interactions up-interacting bins (red) and down-interacting bins (blue), (2) TADs configuration in siCtrl and siAGO1 cells (100-kb resolution), and (3) compartments in siCtrl and siAGO, and (4) differentially expressed genes with upregulated in purple and downregulated in brown (threshold FDR 0.05). The vertical dotted lines reflect compartment switching between siCtrl and siAGO1 cells. (E) Bar plot showing classification of differentially expressed genes into two categories based on integration with AGO1 ChIP-seq and Hi-C data. This plot contains the number of DE genes (FDR threshold 0.05) overlapping with AGO1-bound differentially interacting bins that either associate with different TADs configuration (DI bin + Diff.TAD), and/or compartment switching (DI bin + Comp) between siCtrl and siAGO1 cells. (F and G) CIRCOS plot illustrating the position of significant intra-(F) and inter-(G) chromosomal differential interactions (FDR < 0.001 and logFC > 3), downinteracting regions are linked by blue lines while the up-interacting bins are linked by orange lines. The three circles in the plot represent the following data; 1.Chromosome names, 2.DE genes (FDR 0.05; upregulated genes [red] downregulated genes [blue]), 3.AGO1 ChIP-seq peaks (green). 
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